期刊文献+

腺苷预处理对缺血心肌保护作用的临床研究 被引量:1

Myocardioprotective effect of adenosine preconditioning on open heart surgery
下载PDF
导出
摘要 目的:探讨腺苷预处理在心内直视手术中对缺血心肌的保护效果及其机制。方法:将23例不伴有重度肺动肺高压的先天性心脏病患者随机分为腺苷预处理组(腺苷组,n=12)和对照组(n=11)。对照组在升主动脉阻断后采用常规改良冷St.Thomas液使心脏停跳行心肌保护(20 ml/kg),每30 min重复1次。腺苷组在体外循环(CPB)前缓慢静脉推注腺苷2 mg/kg行预处理,30 min内推完,此后施行和对照组相同的CPB和心肌保护方法。心脏停跳后行心内畸形纠治,完成心内操作后恢复心脏血供。观察心脏自动复跳率及术后心律变化、术后2、6、24和48 h血清肌酸激酶(CK)及其同工酶(CK-MB)、乳酸脱氢酶(LDH)水平和缺血末心肌组织细胞形态学变化。结果:两组均无手术死亡者。腺苷组心脏自动复跳率为91.6%,而对照组为54.5%(P<0.05),对照组1例术后偶发室性早搏,2例需短时应用小剂量血管活性药物。两组血清CK、CK-MB和LDH水平均有升高,但腺苷组在术后不同时点明显低于对照组(P<0.05或P<0.01);对照组心肌组织形态学可见心肌纤维变性、横纹模糊及间质水肿明显,而腺苷组变化较轻。结论:腺苷预处理可减少心肌细胞缺血引起的心肌酶释放,减轻缺血心肌的组织形态学变化,有利于再灌注后减少心律失常的发生和心功能的恢复。 Objective: To explore the myocardioprotective effect and mechanism of adenosine preconditioning in patients undergoing open heart surgery. Methods: Twenty-three patients with simple congenital heart defects were randomly divided into two groups:adenosine preconditioning group (adenosine group, n = 12) and control group ( n = 11 ). The hearts suspended with cool improved St. Thomas cardioplegia (20 ml·kg^-1 ) which was perfused every thirty minutes after aortic-clamping in both groups. Adenosine was administered intravenously to the patients slowly in adenosine group at a dose of 2 mg·kg^-1 before beginning of cardiopulmonary bypass(CPB). The serum concentration of creatine kinase(CK), creatine kinase MB isoenzyme (CK-MB) and lactic dehydrogenase(LDH) from venous blood were measure at different time points after operation. Myocardial tissues were taken from right atrial appendage at the end of the myecardial ischemia time, and the cyto - histo - morphological changes were observed. Results : After heart reperfusion,the proportion of spontaneous returned heartbeat was 91.6% in adenosine group, but 54.5% in control group (P 〈 0.05). The levels of serum CK, CK-MB and LDH in adenosine group were mueh less than those in control group at different time points( P 〈 0.05 or P 〈 0.01 ). The myocardial histo-morphologieal observation showed very metamorphie ehanges in eontrol group, but slighter ehanges in adenosine group. Conclusion: Adenosine precon- ditioning can reduce the release of myocardial enzyme and the isehemie injury of myocardium, which may be. one of the mechanisms of adenosine preconditioning.
出处 《山东大学学报(医学版)》 CAS 北大核心 2006年第8期798-801,共4页 Journal of Shandong University:Health Sciences
基金 山东省自然科学基金(Y2000C17) 山东省医药卫生科研基金(2001CA1CJA14)资助课题
关键词 预处理 腺苷 心肌缺血 心脏外科手术 Preconditioning, adenosine Myocardial ischemia Cardiac surgical procedures
  • 相关文献

参考文献12

  • 1Matsubara T,Minatoguchi S,Matsuo H,et al.Three minutes,but not one minute,ischemia and nicorandil have a preconditioning effect in patients with coronary artery disease[J].J Am Coll Cardiol,2000,35(2):345-351.
  • 2Wu ZK,Livainen T,Pehkonen E,et al.Ischemic preconditioning suppressess ventricular tachyarrhytmias after myocardial revascularization[J].Circulation,2002,106:3 091-3 096.
  • 3Minatoguchi S,Uno Y,Kariya T,et al.Cross-talk among noradrenaline,adenosine and protein kinase C in the mechanisms of ischemic preconditioning in rabbits[J].Cardiovasc Pharmacol,2003,41(Suppl 1):S39-47.
  • 4Eisen A,Fisman EZ,Rubenfire M,et al.Ischemic preconditioning:nearly two decades of research.A comprehensive review[J].Atherosclerosis,2004,172(2):201-210.
  • 5Kerendi F,Kin H,Halkos ME,et al.Romote postconditioning.Brief renal ischemia and reperfusion applied before coronary artery reperfusion reduces myocardial infarct size via endogenous activation of adenosine receptors[J].Basic Res Cardiol,2005,100(5):404-412.
  • 6Baxter GF,Marber MS,Patel VC,et al.Adenosine receptor involvement in a delayed phase of myocardial protection24 hours after ischemic preconditioning[J].Circulation,2004,90(6):2993-3000.
  • 7Uematsu M,Gaudette GR,Laurikka JO,et al.Adenosineenhanced ischemic precond-itioning decreases infarct in the regional ischemic sheep heart[J].Ann Thorac Surg,1998,66(2):382-387.
  • 8Marc JC,Johan B,Michel DC,et al.Effect of intracoronary adenosine infusion during coronary intervention on myocardial reperfusion injury in patients with acute myocardial infarction[J].Am J Cardiol,2004,94(1):9-13.
  • 9Mcgully JD,Toyoda Y,Uemastu M,et al.Adenosine enhanced ischemic preconditioning:adenosine receptor involvement during ischemia and reperfusion[J].Am J Physiol Heart Circ Physiol,2001,280(2):H591-602.
  • 10Tang XL,Xuan YT,Zhu Y,et al.Nicorandil induce late preconditioning against myocardial infarction in conscious rabbits[J].Am J Physiol Heart Circ Physiol,2004,286(4):H1 273-1 280.

同被引文献16

  • 1王倩,闵连秋.脑缺血耐受与药物预处理[J].国外医学(脑血管疾病分册),2004,12(8):593-596. 被引量:3
  • 2朱泽湘.腺苷及腺苷受体与脑缺血耐受[J].实用医学杂志,2004,20(10):1197-1198. 被引量:8
  • 3疏树华,方才.兴奋性氨基酸及受体与脑损伤的研究进展[J].立体定向和功能性神经外科杂志,2007,20(2):124-126. 被引量:26
  • 4[4]Longa EZ,Weinstein PR,Carlson S,et al.Reversible middle cerebral artery occlusion without craniectomy in rats[J].Stroke,1989,20(1):84-91.
  • 5[7]Liu HT,Hollmann MW,Liu WH,et al.Modulation of NMDA receptor function by ketamine and magnesium[J].Anesth Analg,2001,92(5):1173-1181.
  • 6[8]Yu SP,Yeh C,Strasser U,et al.NMDA receptor mediated K+ efflux and neuronal apoptosis[J].Science,1999,284(5412:336-339.
  • 7[9]Olney JW.Brain lesions,obesity and other disturbances in mice treated with monosodium glutamate[J].Science,1969,164(880):719-721.
  • 8[10]Lang AE,Gill S,Patel NK,et al.Randomized controlled trial of intraputamenal glial cell line derived neurotrophic factor infusion in Parkinson's disease[J].Ann Neuro,2006,59(3):459-466.
  • 9[12]Zhang J,Benveniste H,Klitzman B,et al.Nitric oxide synthase inhibition and extracellular glutamate concentration after cerebral ischemia reperfusion[J] Stroke,1995,25(2):298-304.
  • 10[13]Shryock JC,Belardinelli L.Adenosine and adenosine receptors in the cardiovascular system:biochemistry,physiology and pharmacology[J].Am J Cardiol,1997,79(12A):2-10.

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部